Evelo Biosciences, Inc. (EVLO): Price and Financial Metrics

Evelo Biosciences, Inc. (EVLO): $0.04

0.01 (-11.92%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add EVLO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#207 of 343

in industry

EVLO Price/Volume Stats

Current price $0.04 52-week high $13.93
Prev. close $0.05 52-week low $0.03
Day low $0.04 Volume 17,500
Day high $0.05 Avg. volume 42,361
50-day MA $0.05 Dividend yield N/A
200-day MA $2.41 Market Cap 827.66K

EVLO Stock Price Chart Interactive Chart >


Evelo Biosciences, Inc. (EVLO) Company Bio


Evelo Biosciences, Inc. focuses on the development of monocolonal microbials for the treatment of inflammatory diseases and cancer. It is involved in developing EDP1066 and EDP1815 for patients with psoriasis and atopic dermatitis, rheumatoid arthritis, and ulcerative colitis/crohn’s colitis; and EDP1503 for the treatment of colorectal cancer, renal cell carcinoma, and melanoma, as well as patients who have relapsed on prior PD-1/L1 inhibitor treatment across multiple tumor types. The company was founded in 2014 and is based in Cambridge, Massachusetts.


EVLO Latest News Stream


Event/Time News Detail
Loading, please wait...

EVLO Latest Social Stream


Loading social stream, please wait...

View Full EVLO Social Stream

Latest EVLO News From Around the Web

Below are the latest news stories about EVELO BIOSCIENCES INC that investors may wish to consider to help them evaluate EVLO as an investment opportunity.

Flagship-backed microbiome biotech Evelo to shut down

The company said it had not found “a viable alternative” to closing down in the months since it hit a clinical setback and laid off staff.

Yahoo | November 22, 2023

Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript

Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript November 1, 2023 Operator: Greetings, and welcome to Horizon Technology Finance Corporation Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being […]

Yahoo | November 2, 2023

Q3 2023 Horizon Technology Finance Corp Earnings Call

Q3 2023 Horizon Technology Finance Corp Earnings Call

Yahoo | November 2, 2023

Evelo (EVLO) Drops 59% on Flunking Psoriasis Drug Study

Evelo's (EVLO) EDP2939 fails to achieve the primary endpoint in a mid-stage for treating moderate psoriasis. The company decides to cease clinical development on the candidate.

Yahoo | October 18, 2023

Biotech Stock Roundup: ALDX, EVLO Down on Setback, SRRK Offers Updates & More

Regulatory and pipeline updates from Aldeyra Therapeutics (ALDX) and Scholar Rock (SRRK) are in focus in the biotech sector.

Yahoo | October 18, 2023

Read More 'EVLO' Stories Here

EVLO Price Returns

1-mo -33.99%
3-mo -41.94%
6-mo -93.44%
1-year -98.67%
3-year -99.98%
5-year -99.98%
YTD -34.96%
2023 -99.81%
2022 -73.48%
2021 -49.79%
2020 197.78%
2019 -68.79%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!